MedPharm || طبصيدلة
Kanalga Telegram’da o‘tish
شرح مادة الصيدلة السريرية clinical pharmacology 🧑🏻⚕️ معرف التلي: mohammedsalim10 Instagram: _a1mh
Ko'proq ko'rsatishMamlakat belgilanmaganToif belgilanmagan
3 508
Obunachilar
Ma'lumot yo'q24 soatlar
-147 kun
-5830 kun
Postlar arxiv
3 507
A young woman suffered from depression. She has a history of anorexia nervosa. What is the antidepressant that should not be used for this patient?
3 507
A breast feeding woman was diagnosed to have depression. Which one of the following antidepressant drugs is the preferred one in this case?
3 507
The electroconvulsive therapy (ECT) may be considered as option for depressed patients in all the following cases EXCEPT
3 507
An antidepressant drug that can cause anticholinergic side effects (eg. dry mouth, blurred vision, constipation,) and sedation is
3 507
Clearance of triazolam is reduced and plasma concentration is elevated with all these
agents, except:
3 507
All the antidepressants below are good sedatives for insomnia EXCEPT:
3 507
J.F is 36 years man with insomnia and history of crystal (methamphetamine) abuse.
What is the preferred drug for treatment of JF insomnia?
3 507
patient with chronic insomnia was treated by zolpidem and educated about sleep hygiene. Which one of the following statements regarding the evaluation of therapeutic outcome for this patient is true?
a- After 1 week of therapy, the patient should be assessed for drug adherence, effectiveness, and adverse events
b- After 7 days of therapy, the patient should be assessed for drug effectiveness, adverse events, and adherence to non-pharmacologic recommendations
c- After 1 week of therapy, the patient should be assessed for drug effectiveness, and adverse events
d- After 1 month of therapy, the patient should be assessed for drug effectiveness, adverse events, and adherence to non-pharmacologic recommendations
e- None of the above
3 507
A.J. is 53 years old man who suffers from insomnia in the last 2.5 months. What can you consider the type of insomnia for this patient?
3 507
Z.L is 38 years old female suffers from insomnia. She has a medical history of glaucoma and depression. What is the best sedative for her?
3 507
M.K. is 47 years-old man who requested a treatment that can help him fall asleep rapidly and does not affect his ability to drive his taxi in the early morning. He has concerns about rebound insomnia. Which one of the following drugs is the best for treating the patient case?
3 507
Obstructive sleep apnea (OSA) is potentially life-threatening and characterized by repeated episodes of nocturnal breathing cessation followed by blood oxygen desaturation. Which one of the following drugs is approved by the FDA to improve wakefulness in those with residual daytime sleepiness?
3 507
The nonbenzodiazepine hypnotic drug has a rapid onset, a half-life of ~1 hour, and no active metabolites. It decreases time to sleep onset, but does not increase the total sleep time. It does not appear to cause next-day psychomotor impairment
3 507
The most common treatments for cataplexy involve the followings, EXCEPT:
3 507
Concerning the pathophysiology of obstructive sleep apnea, obstructive sleep apnea may be associated with the following conditions EXCEPT:
